A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Trial details
- Registry ID
- NCT07459647
- Drugs studied
- ML-007C-MA
TrialRedline tracks 6 clinical trials sponsored by MapLight Therapeutics: 6 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaNCT07459647 | ML-007C-MA | Recruiting | 2030-02Estimated |
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisNCT06887192 | ML-007C-MA | Recruiting | 2027-12Estimated |
| An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisNCT07459660 | ML-007C-MA | Enrolling by invitation | 2029-03Estimated |
| ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)NCT05889273 | ML-004 (IR)/(ER) tablet | Active not recruiting | 2027-11Estimated |
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaNCT07038876 | ML-007C-MA BID, ML-007C-MA QD | Completed | 2026-06-04Actual |
| ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)NCT05081245 | ML-004 (IR)/(ER) tablet | Completed | 2026-03-10Actual |
Names as written in the registry records.
NCT07459660 · MapLight Therapeutics
Before: Recruiting. After: Enrolling by invitation.
NCT05889273 · MapLight Therapeutics
Before: Enrolling by invitation. After: Active not recruiting.
NCT07038876 · MapLight Therapeutics
Before: Estimated. After: Actual.
Before: Aug 2026. After: 4 Jun 2026.
Before: Active not recruiting. After: Completed.
NCT05081245 · MapLight Therapeutics
Before: Estimated. After: Actual.
Before: 150 participants (planned). After: 168 participants (actual).
Before: Estimated. After: Actual.
Before: Oct 2026. After: 10 Mar 2026.
Before: Active not recruiting. After: Completed.
NCT07038876 · MapLight Therapeutics
Before: Estimated. After: Actual.
Before: 300 participants (planned). After: 307 participants (actual).
Before: Recruiting. After: Active not recruiting.
NCT07459647 · MapLight Therapeutics
Before: Not yet recruiting. After: Recruiting.
NCT07459660 · MapLight Therapeutics
Before: Not yet recruiting. After: Recruiting.
NCT07038876 · MapLight Therapeutics
Before: Jan 2027. After: Aug 2026.
NCT06887192 · MapLight Therapeutics
Before: Feb 2027. After: Dec 2027.
NCT05081245 · MapLight Therapeutics
Before: Recruiting. After: Active not recruiting.